( 55 of 55 ) |
United States Patent | 5,498,788 |
Zmitek , et al. | March 12, 1996 |
Described is a new process for the preparation of alkali clavulanate from an aqueous solution of pure clavulanic acid and of pharmaceutically acceptable potassium crude clavulanic acid, which is obtained in a conventional manner after the fermentation with a clavulanic-acid-producing microorganism, extracted with an ethyl acetate solution of a hydrophobic .beta.-CD derivative such as heptakis-(2,3,6-tri-O-acetyl)-.beta.-CD in equimolar amount or up to 10% excess with regard to clavulanic acid. The resulting novel inclusion complexes of clavulanic acid and hydrophobic .beta.-CD derivative in a molar ratio about 1:1 are isolated, purified with water and then converted with potassium 2-ethyl hexanate to the potassium clavulanate, which is isolated. Furthermore, there are described new inclusion complexes of clavulanic acid and of its pharmaceutically acceptable potassium salt both with hydrophilic .beta.-CD derivatives and with hydrophobic .beta.-CD derivatives, processes for the preparation thereof and the use thereof for the preparation of galenic forms with immediate as well as with sustained action, in combination with amoxicillin trihydrate, which are valuable medicaments in the therapy of infectious diseases.
Inventors: | Zmitek; Janko (Ljubljana, SI), Fercej-Temeljotov; Darja (Ljubljana, SI), Verhnjak; Katarina (Ptuj, SI), Kotnik; Sonja (Ljubljana, SI), Kovacic; Mateja (Ljubljana, SI) |
Assignee: |
LEK, tovarna farmacevtskih
(SI)
|
Appl. No.: | 08/369,301 |
Filed: | January 6, 1995 |
Application Number | Filing Date | Patent Number | Issue Date | ||
84951 | Jul., 1993 | ||||
Jul 08, 1992 [SI] | P-9200139 | |||
Current U.S. Class: | 540/349 ; 424/470; 536/103 |
Current International Class: | A61K 47/48 (20060101); A61K 31/424 (20060101); C07D 487/04 (); A01K 009/26 () |
Field of Search: | 424/490 540/349 |
4454069 | June 1984 | Cook et al. |
4525353 | June 1985 | Cole et al. |
4647659 | March 1987 | Cook et al. |
4869904 | September 1989 | Uekama et al. |
5310898 | May 1994 | Copar |
1508977 | Apr., 1978 | GB | |||
Lenga, Robert, The Sigma-Aldrich Library of Chemical Safety Data, Edition 1, 1985, p. 310. . Bekers, et al., Cyclodextrins in the Pharmaceutical Field, Drug Development and Industrial Pharmacy, vol. 17, No. 11 (1991), pp. 1503-1549. . Chemical Abstracts, The American Chemical Society, vol. 101, No. 21 (1984), p. 808. . Hedges, Allan, Minutes of the Sixth International Symposium on Cyclodextrins, Symposium organized by American Maize-Products Company, (1992) pp. 1-8. . Matsubara, et al., Possible Use of Triacetylated Cyclodextrins in the Preparation of Sustained-Release Oily Injection of LHRH Agonist, Buserelin Acetate, pp. 547-550. . Karuzomi et al in Chem. Pharm. Bull vol. 23, pp. 3062-3068 (1975).. |